Document:

Carusa Industries, Inc. Amended and Restated Restoration Plan

 Exhibit 10.30 
  
 CARAUSTAR INDUSTRIES, INC. 
 RESTORATION PLAN 
 This Plan, as established by Caraustar Industries, Inc. effective as of November 22, 1996, and as thereafter
amended on February 7, 2002, August 11, 2005, October 13, 2005, November 7, 2005, and is further amended and restated December 29, 2006, retroactively effective to the 1st day of January 2005 for the primary
purpose of complying with Section 409A of the Internal Revenue Code of 1986, as amended, and applicable Treasury or Internal Revenue Code guidance issued there under. 
 This document applies to persons separating from service after December 31, 2004. 
 ARTICLE 1 –
PURPOSE OF PLAN 
  

	Section 1.1	Purpose: The purpose of this Plan is to provide supplemental retirement benefits to certain named Caraustar Industries, Inc. Executives. The benefits to be provided under
this Plan are intended to supplement other retirement benefits provided by the Company through plans qualified under Section 401(a) of the Internal Revenue Code of 1986, nonqualified plans, and the federal Social Security system of the United
States. 

  

	Section 1.2	Design: The Plan is designed to provide supplemental retirement benefits as described in Section 3.4 and is intended to be an unfunded plan providing deferred
compensation for a select group of highly compensated or management employees. 

 ARTICLE 2 – DEFINITIONS

  

	Section 2.1	Average Annual Compensation: The average of the Executive’s annual Compensation over the five (5) consecutive calendar years during the ten (10) most recent
calendar years (including the calendar year in which the Executive’s Payment Event occurs) which produces the highest average, or, if the Executive has less than five (5) consecutive years of service, the average of the Executive’s
annual Compensation for his or her full calendar years of Service. 

  

	Section 2.2	Beneficiary: The Spouse of the Executive as of his Payment Event. If the Spouse predeceases the Executive or the Executive has no Spouse, the beneficiary is the person
designated by the Executive to be the beneficiary in such event, or the Executive’s estate if no person has been designated by the Executive as the beneficiary. 

  

	Section 2.3	Board: The Board of Directors of Caraustar Industries, Inc. 

	Section 2.4	Calculation Date: With respect to any Executive, the date on which his Payment Event occurs. 

  

	Section 2.5	Change-In-Control: means the occurrence of any one of the following events provided such event also constitutes a “change in control” within the meaning of
Section 409A: 

  

	 	 (a)
	 individuals who, on the date hereof, constitute the Board (the “Incumbent Directors”) cease for any
reason to constitute at least a majority of the Board, provided that any person becoming a director subsequent to the date hereof whose election or nomination for election was approved by a vote of at least two thirds ( 2/3) of the Incumbent Directors then on the Board (either by a specific vote or by approval of the proxy
statement of the Company in which such person is named as a nominee for director, without written objection to such nomination) shall be an Incumbent Director; 

  

	 	(b)	any “person” (as such term is defined in Section 3(a)(9) of the Securities Exchange Act of 1934 (the “Exchange Act”) and in Sections 13(d)(3) and
14(d)(2) of the Exchange Act) is or becomes a “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 25% or more of the combined voting power of the
Company’s then outstanding securities eligible to vote for the election of the Board (the “Company Voting Securities”); provided, however, that such event shall not be deemed to be a Change in Control by
virtue of any acquisition of Company Voting Securities (A) by the Company or any Subsidiary, (B) by any employee benefit plan (or related trust) sponsored or maintained by the Company or any Subsidiary, (C) by any underwriter
temporarily holding securities pursuant to an offering of such securities, (D) pursuant to a Non-Qualifying Transaction (as defined in Section 2.5(c)), (E) pursuant to any acquisition by an Executive or any group of persons
including Executive (or any entity controlled by an Executive or by any group of persons including Executive); or (F) pursuant to or in connection with a transaction (other than a Business Combination) in which Company Voting Securities are
acquired from the Company, if a majority of the Incumbent Directors approve a resolution providing expressly that such transaction does not constitute a Change in Control under this Section 2.5(b); 

  

	 	(c)	 the consummation of a merger, consolidation, statutory share exchange or similar form of corporate transaction involving the Company or any of its Subsidiaries that
requires the approval of the Company’s shareholders, whether for such transaction or for an issuance of securities in or in connection with the transaction (a “Business Combination”), unless immediately following such
Business Combination (A) more than 50% of the total voting power of the ultimate parent corporation that directly or indirectly has beneficial ownership of 100% of the voting securities 

  

 2 

	 	 
eligible to elect directors of the Surviving Corporation (the “Parent Corporation”) or, if there is no Parent Corporation, the corporation
resulting from such Business Combination (the “Surviving Corporation”), is represented by Company Voting Securities that were outstanding immediately prior to such Business Combination (or, if applicable, is represented by shares
into which such Company Voting Securities were converted pursuant to such Business Combination), and such voting power among the holders thereof is in substantially the same proportion as the voting power of such Company Voting Securities among the
holders thereof immediately prior to the Business Combination, (B) no person (other than any employee benefit plan or related trust sponsored or maintained by the Surviving Corporation or the Parent Corporation), is or becomes the beneficial
owner, directly or indirectly, of 25% or more of the total voting power of the outstanding voting securities eligible to elect directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) and (C) at
least a majority of the members of the board of directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) following the consummation of the Business Combination were Incumbent Directors at the time of the
Board’s approval of the execution of the initial agreement providing for such Business Combination (any Business Combination that satisfies all of the criteria specified in clauses (A), (B) and (C) above shall be deemed to be a
“Non-Qualifying Transaction”); or 

  

	 	(d)	the Company acts upon a plan of complete liquidation or dissolution of the Company approved by the shareholders of the Company or effects a sale of all or substantially all of the
Company’s assets approved by the shareholders of the Company. 

 Notwithstanding the foregoing, a Change in Control of the
Company shall not be deemed to occur solely because any person acquires beneficial ownership of more than 25% of the Company Voting Securities as a result of an acquisition or a series of acquisitions of Company Voting Securities by the Company that
reduces the number of Company Voting Securities outstanding; however, if such person thereafter becomes the beneficial owner of additional Company Voting Securities that increase the percentage of outstanding Company Voting Securities beneficially
owned by such person, a Change in Control of the Company shall then be deemed to occur. 
  

	Section 2.6	Code: The Internal Revenue Code of 1986, as amended, or as it may be amended from time to time. 

  

	Section 2.7	Company: Caraustar Industries, Inc. 

  

	Section 2.8	 Compensation: Wages as defined in Section 3401(a) of the Code for the purposes of income tax withholding at the source but determined without regard to
any rules that limit the remuneration included in wages based on the nature or 

  

 3 

	 	 
location of the employment or the services performed (such as the exception for agricultural labor in Section 3401(a)(2)), reduced by all of the following
items (even if includible in gross income): reimbursements or other expense allowances, fringe benefits (cash and noncash), moving expenses, deferred compensation, and welfare benefits. Compensation shall also include any amount which is contributed
by the Company pursuant to a salary reduction agreement and which is not includible in the Executive’s gross income under Sections 125, 402(a)(8), 402(h), or 403(b) of the Code. 

  

	Section 2.9	Compensation and Employee Benefits Committee: The Compensation and Employee Benefits Committee as established by the Board. 

  

	Section 2.10	Covered Compensation: For the Executive, the amount determined for the calendar year in which he attains or will attain his Social Security Retirement Age using the Covered
Compensation Table in Internal Revenue Service Revenue Ruling 93-20 (or any successor table as updated and issued by the Internal Revenue Service from time to time) as in effect for the calendar year in which his employment with the Employer
terminates. No increase in Covered Compensation shall decrease the Executive’s amount of benefits under this Plan after his Calculation Date. 

  

	Section 2.11	Early Retirement Adjustment Factor: 

  

							
	 Age Benefit Begins
	  	 Factor
	  	 Age Benefit Begins
	  	 Factor

	 64
	  	.9231	  	59	  	.6538
	 63
	  	.8462	  	58	  	.6154
	 62
	  	.7692	  	57	  	.5769
	 61
	  	.7308	  	56	  	.5292
	 60
	  	.6923	  	55	  	.4862

 The Early Retirement Adjustment Factors are interpolated for retirement at an age in between
whole ages. 
  

	Section 2.12	Early Retirement Age: The age of the Executive on the first date upon which the Executive both has attained age fifty-five (55) and has completed ten (10) or more
years of Vesting Service as defined in the Retirement Plan. 

  

	Section 2.13	Employee: A participant in the Caraustar Industries, Inc. Retirement Plan or in the Caraustar Industries, Inc. Employees’ Savings Plan. 

  

	Section 2.14	Executive: A participant in the Plan as appointed by the Chief Executive Officer, upon receiving approval from the Compensation and Employee Benefits Committee.

  

	Section 2.15	 Final Average Compensation: The average annual Compensation for the three (3) consecutive calendar years in which the Executive was employed by the

  

 4 

	 	 
Company immediately preceding his Payment Event excluding the calendar year in which his Payment Event occurs, or, if the Executive’s entire period of
service with the Employer is less than three (3) consecutive calendar years, the average of this annual Compensation for his full calendar years of Service. For purposes of this Section, Compensation for any year in excess of the taxable wage
base in effect at the beginning of such year shall not be taken into account. 

  

	Section 2.16	Hour of Service: Each hour for which an Employee is paid, or entitled to payment, for the performance of duties for the Company as an Employee during any period of
employment. 

  

	Section 2.17	Normal Retirement Age: Age sixty-five (65). 

  

	Section 2.18	Normal Retirement Date: The first day of the month coincident with or next following the date the Executive attains his Normal Retirement Age. 

  

	Section 2.19	Payment Event: With respect to any Executive, the first to occur of his Retirement Date, death, the date he Separates from Service as a result of a Total and Permanent
Disability, or a Change-In-Control. 

  

	Section 2.20	Plan: The “Caraustar Industries, Inc. Restoration Plan”, as set forth herein or in any amendment hereto. 

  

	Section 2.21	Plan Administrator: The individual or committee appointed pursuant to Article 7 of the Retirement Plan, who shall have the same powers and those duties with respect to the
Plan as those described in Article 7 of the Retirement Plan. The Plan Administrator is the named fiduciary for purposes of the Employee Retirement Income Security Act of 1974 as amended. 

  

	Section 2.22	Plan Year: The calendar year. 

  

	Section 2.23	Retirement Benefit: The Accrued Benefit determined in Section 3.1 multiplied by the Early Retirement Adjustment Factor if the Retirement Date precedes the Normal
Retirement Date. 

  

	Section 2.24	Retirement Date: The first day of the month coincident with or next following the date the Executive attains his Early Retirement Age or Normal Retirement Age and actually
terminates employment with the Company. 

  

	Section 2.25	Retirement Plan: The Caraustar Industries, Inc. Retirement Plan for the Employees of Caraustar Industries, Inc., as amended from time to time. 

  

	Section 2.26	Section 409A: Section 409A of the Code and applicable Treasury or Internal Revenue Service guidance issued thereunder. 

  

	Section 2.27	 Service: An Employee shall be credited with one (1) year of Service for each Plan Year during which he completes one thousand (1,000) or more Hours
of Service with the Company. An Employee shall also be credited with Service 

  

 5 

	 	 
solely for purposes of determining his Accrued Benefit under Section 3.1 (but not for purposes of vesting under Section 3.4) for employment with an
employer other than the Company provided the Chief Executive Officer makes a qualifying recommendation and such recommendation is endorsed by the Board’s Compensation and Employee Benefits Committee. 

  

	Section 2.28	Separation from Service: A “separation from service” within the meaning of Section 409A. 

  

	Section 2.29	Specified Employee: An Executive or a former Executive shall be a specified employee if on any date in the applicable period, he is an employee of the Company or any
affiliate of the Company that would be consider a single employer with the Company under Section 414(a) or (b) of the Internal Revenue Code of 1986, as amended, (the “Code”) who was a “key employee” within the meaning
of Section 416(i) of the Code (without regard to paragraph (5) thereof) at any time during the 12-month period ending on the identification date. For the period beginning January 1, 2005 and ending March 30, 2006, the
identification date is December 31, 2004. Thereafter, the applicable period is each 12-month period beginning on April 1, 2006 and each subsequent April 1 and the identification date for each such period is the immediately preceding
December 31. For example, for the period beginning April 1, 2006, the identification date is December 31, 2005. Specified Employees shall be determined in accordance with Section 409A. 

  

	Section 2.30	Spouse: The individual to whom the Executive is legally married as of the earlier of the Executive reaching his Retirement Date, suffering a Total and Permanent Disability
(as defined in Article 1 of the Retirement Plan and in accordance with a determination made by the Social Security Administration), death, or upon the Change-In-Control of the Company. 

  

	Section 2.31	Total and Permanent Disability: The event shall have the meaning specified in Article 1 of the Retirement Plan, but limited to Social Security Administration approved
disability. 

 ARTICLE 3 – BENEFITS 
  

	Section 3.1	Accrued Benefit: The Accrued Benefit is an annual amount payable in the form of a Life Annuity, calculated as of the Executive’s Calculation Date, equal to the product
of (a) times (b) minus (c) where: 

  

	 	(a)	Is 1.35% of Average Annual Compensation times years of Service projected to Normal Retirement Date, offset by .65% of Final Average Compensation up to Covered Compensation times
years of Service projected to Normal Retirement Date, and 

  

	 	(b)	Is a fraction where the numerator is years of Service as of the Calculation Date and the denominator is the greater of years of Service as of the Calculation Date or years of
Service projected to Normal Retirement Date, and 

  

 6 

	 	(c)	Is the Executive’s accrued benefit under the Retirement Plan as of the Calculation Date, the accrued benefit under any Company paid deferred compensation arrangements as of the
Calculation Date other than the Caraustar Industries, Inc. Employees’ Savings Plan (the Caraustar 401(k) Plan), and/or any other accrued benefit payable through another employer’s qualified defined benefit plan as of the Calculation Date
by which the Executive has obtained additional years of Service. Notwithstanding the above, the Executive’s accrued benefit is also reduced by the actuarial equivalent of a hypothetical benefit account based on accumulating the Executive’s
service-weighted retirement contributions under the Caraustar’s 401(k) Plan with interest using for each calendar year the 10-year Treasury Bond constant maturity rate, monthly average yield for the December preceding such year. Actuarial
equivalence for this purpose will be on the same basis used for the optional forms of payment herein. If a benefit of another employer is offset hereunder and is not in the form of a Life Annuity payable at age 65, Caraustar’s actuary shall
determine the equivalent Life Annuity at age 65 for the purpose of determining the offset amount. 

  

	Section 3.2	Forms of Benefit Payment and Election Requirements: 

  

	 	(a)	Normal Form of Payment: Unless otherwise elected, the form of benefit payment for a Retirement Payment under Section 3.4(a)(1) or Disability Payment under
Section 3.4(a)(2) shall be a 5-year Certain Annuity. The 5-Year Certain Annuity is equal to the actuarial equivalent of the Retirement Benefit. The benefits under a 5-Year Certain annuity are payable in 60 monthly installments to the Executive
while the Executive is alive and continuing to the Beneficiary for the balance of the 60 payments remaining after the death of the Executive. The amount benefit under this Normal Form of Payment and the rules for payments after the death of the
Executive or the Executive’s Beneficiary will be determined in the same manner as described below for a 10-Year Certain Annuity. 

 The normal form of payment for a Death Payment shall be a Life Annuity. The normal form of Payment for a Change-In-Control Payment shall be a lump sum. 
  

	 	(b)	Optional Forms: In lieu of the Normal Form, the Executive may elect to receive his Retirement payment under Section 3.4(a)(1) in any of the following optional forms of
payment. The Disability Payment under Section 3.4(a)(2) shall be paid in the same form of payment elected for the Retirement Payment. The optional forms of payment are: 

  

 7 

	 	(1)	10-Year Certain Annuity: The 10-Year Certain Annuity is the actuarial equivalent benefit of the Retirement Benefit. The 10-Year Certain Annuity is payable in 120 monthly
installments to the Executive while the Executive is alive and continuing to the Executive’s Beneficiary for the balance of the 120 payments remaining after the death of the Executive. Such actuarial equivalent shall be determined using the
mortality table prescribed in Rev. Rul. 2001-62 and the interest rate most recently used as of the benefit commencement date (or the date that would be the benefit commencement date except for Plan Section 3.4(b)) to discount this Plan’s
liabilities for FAS 87 purposes. 

 If the Beneficiary who is receipt of monthly payments by reason of the Executive’s
death, dies before a total of 120 payments have been paid to the Executive and the Beneficiary, then the present value of the remaining payments (determined using the interest rate most recently used to discount this Plan’s liabilities for FAS
87 purposes) will be paid to the Beneficiary’s estate. If the Executive’s named Beneficiary predeceases the Executive, and the Executive dies before a total of 120 monthly payments have been made to the Executive, the present value of the
remaining payments (determined using the interest rate most recently used to discount this Plan’s liabilities for FAS 87 purposes) will be paid to the Executive’s estate. 
  

	 	(2)	Life Annuity: Equal to the Retirement Benefit payable monthly for the life of the Executive. 

  

	 	(3)	Joint and 50% Survivor Annuity: Equal to the actuarial equivalent of the Retirement Benefit (using the mortality table prescribed in Rev. Rul. 2001-62 and the interest rate most
recently used to discount this Plan’s liabilities for FAS 87 purposes) payable monthly for the life of the Executive with a survivor annuity of half of such amount continuing for the life of the Spouse following the death of the Executive.

  

	 	(4)	Joint and 100% Survivor Annuity Survivor Annuity: Equal to the actuarial equivalent of the Retirement Benefit (using the mortality table prescribed in Rev. Rul. 2001-62 and the
interest rate most recently used to discount this Plan’s liabilities for FAS 87 purposes) payable monthly for the life of the Executive with a survivor annuity equal to the amount that the Executive was receiving with such amount continuing for
the life of the Spouse following the death of Executive. 

  

 8 

	 	(c)	If the Executive elects a Joint and 50% Survivor Annuity and the Executive’s Spouse dies prior to the Executive’s commencement of benefits, his benefit automatically will
be paid in a Life Annuity. 

  

	 	(d)	Executive’s benefit will commence on his Retirement Date. Notwithstanding the above, the Executive may elect as provided in paragraph (e) below to have his benefits
commence on his Normal Retirement Date. In such case the Executive’s benefit will be computed without adjustment for early retirement. 

  

	 	(e)	The Executive’s election as to form of payment and the time of payment must be made in writing no later than 30 days after first becoming eligible to participate in this Plan.

 Notwithstanding the above, an Executive who was participating in the Plan before January 1, 2005, may make a new
election during 2005 or 2006, except that the Executive cannot make an election in 2006 that would either cause payments to be made to him in 2006 or postpone any payments that would otherwise be due to him in 2006 to 2007 or later. 
 An Executive who has made an election under this paragraph (e) may change such election as long as change is made not later than the last day
permitted for making such election. 
  

	 	(f)	No Change in Election Permitted After Deadline for Elections: Except as otherwise provided in paragraph (e), once an Executive makes an election, such election may not be
changed. 

  

	Section 3.3	Forfeiture of Benefit: If the Executive engages in any acts or omissions constituting dishonesty, intentional breach of fiduciary obligation or intentional wrongdoing, in
each case that results in substantial harm to the business or property of the Company, he shall forfeit and be ineligible to receive any benefits under this Plan, and any benefits paid to such Executive (or Beneficiary) can be recovered by the
Company. The recovery of any benefits paid to such Executive shall not preclude the Company from taking any other actions against the Executive. 

  

	Section 3.4	Benefit Payments: 

  

	 	(a)	If a Payment Event occurs with respect to the Executive while he is employed with the Company, then he (or his Beneficiary) shall be entitled to receive benefits as follows:

  

	 	(1)	 Retirement Payment: In the event that an Executive Separates from Service on or after his Early Retirement Age or Normal Retirement Age, the Executive will
be paid a Retirement Benefit payable as of the Executive’s Retirement Date or, if so elected, his Normal Retirement Date, adjusted according to the form of 

  

 9 

	 	 
payment elected by the Executive. If benefits are payable before the Executive’s Normal Retirement Age, such benefits shall be reduced for early
commencement by multiplying the accrued benefit by the Early Retirement Adjustment Factors based on the Executive’s age on the date of commencement. 

  

	 	(2)	Disability Payment: In the event that an Executive Separates from Service as a result of a Total and Permanent Disability and such disability occurs prior to the
Executive’s Early or Normal Retirement Date, a Retirement Benefit will be payable as of the first day of the month coincident with or next following the second anniversary of the date the Executive Separates from Service; provided, however,
that an Executive may elect at least one year in advance of the second anniversary of the date he Separates from Service to defer receipt of such benefit until the first day of the month coincident with or next following the later of the seventh
anniversary of the date the Executive Separates from Service or his Normal Retirement Age, but such election to defer receipt of benefits shall not be effective for twelve (12) months after the date such election is made. The form of payment
shall be the same form of payment that is applicable for a Retirement Payment. 

 If disability benefits are payable before the
Executive’s Normal Retirement Age, such benefits shall be reduced for early commencement by multiplying the accrued benefit by the Early Retirement Adjustment Factors based on the Executive’s age on the date of commencement. If the
Disability Payment commences before age 55, then the benefit shall be further reduced by 1/360th for each month that the Executive’s age on date of commencement precedes age 55. 
 If a disabled Executive recovers from disability before his Normal or Early Retirement Age, then any disability benefits he is receiving shall cease.

  

	 	(3)	Death Payment: In the event that the Executive dies before his or her Retirement Date, has five (5) or more years of Service, and has been married for at least one year
prior to his death, the Spouse shall receive a Life Annuity the monthly benefit under which is equal to 50% of the monthly amount that would have been payable to the Executive under the Joint and 50% Survivor Annuity form and such amount shall be
payable as of the first day of the month coincident with or next following the later of the Executive’s death or the date on which the Executive would have reached age 55. If the Spouse benefits commence before the Executive’s Normal
Retirement Date, they will be reduced according to the Early Retirement Adjustment Factor based on the Executive’s age (or age the Executive would have been had he survived) on the date of benefit commencement. 

  

 10 

 If the Executive dies on or after his Retirement date and before his benefits commence, the benefits
will be paid according to the form of payment applicable to the Executive. 
  

	 	(4)	Change-In-Control: Except as provided in Section 3.3, in the event that there is a Change-In-Control of the Company, the Executive shall become fully vested and receive
an immediate lump-sum distribution on the date that is thirty (30) days after the Change in Control or, if such date is not a business day, on the immediately following business day, and the Plan shall terminate after each such Executive has
been paid. The lump sum distribution shall be equal to the greater of (i) the present value of the Retirement Benefit payable in a Life Annuity calculated as of the Payment Event, or (ii) the present value of the Accrued Benefit deferred to
Normal Retirement Age; with such present values being determined using the actuarial equivalent definition for lump sum payments in the Retirement Plan, including the mortality table and interest rate specified therein. 

  

	 	(b)	Delay for Specified Employees: Notwithstanding the above provisions of this Section 3.4, if the Executive is a Specified Employee at the time of the Payment Event, the
commencement of his Retirement Payments or Disability Payments shall be delayed for a period of six months following the Executive’s date of Separation from Service. After the passage of this six-month period, the first payment thereafter shall
include any payments that were missed during the six-month delay plus interest at the same interest rate used to determine an optional form of payment under this Plan as of the date of the Executive’s Separation from Service. Should the
Executive die during the six-month period, any death payments under this Plan are not subject to the six-month delay rule of this paragraph. 

  

	 	(c)	No Hardship: No hardship withdrawals shall be permitted from this Plan. 

  

	Section 3.5	Mental or Legal Incompetence: The Company, in its sole discretion, may make distribution to the guardian or other legal representative of the Executive or Beneficiary, if the
Executive or Beneficiary is determined by a court of proper jurisdiction to be mentally or legally incompetent to receive such benefit distribution. Any such distribution shall be in full and complete satisfaction of any and all claims whatsoever by
or on behalf of such Executive under this Plan against the Company, the Plan Administrator, any member of the Board, other Executives or officers of the Company, other employees, shareholders and any other person acting on behalf of them.

  

 11 

 ARTICLE 4 – MISCELLANEOUS 
  

	Section 4.1	Amendment or Termination: The Chief Executive Officer, upon receiving approval from the Compensation and Employee Benefits Committee, shall have the right to amend this Plan
from time to time and to terminate this Plan at any time; provided, however, no such action shall reduce the Accrued Benefit, as of the date of such action, of any Executive whose benefits hereunder are vested, or defer the time for paying such
benefits under Section 3.4. 

  

	Section 4.2	Company Liability: Nothing in this Plan shall be construed to limit in any way the right of the Company to terminate the employment of the Executive at any time; or to be
evidence of any agreement or understanding, express or implied, that the Company or any affiliate company will employ the Executive in any particular position or at any particular rate or remuneration or for any particular period of time.

  

	Section 4.3	Indemnification: The Company shall indemnify and hold harmless the Administrator, any member thereof and any employee who may act on behalf of the Company in the
administration of this Plan from and against any liability, loss, cost or expense (including reasonable attorney’s fees) incurred at any time as a result of or in connection with any claims, demands, actions or causes of action of the
Executive, any person claiming through or under any of them, or any other person, party or authority claiming to have an interest in this Plan or standing to act for any persons or groups having an interest in this Plan, for or on account of, any of
the acts or omissions (or alleged acts or omissions) of the Administrator, any member thereof or any such employee, except to the extent resulting from such person’s willful misconduct. 

  

	Section 4.4	Tax Effects: The Company makes no warranties or representations with regard to the tax effects or results of this Plan. The Executive participating under this Plan shall be
deemed to have relied upon his own tax advisors with regard to such effects. 

  

	Section 4.5	No Assignment; Binding Effect: Neither the Executive nor Beneficiary shall have the right to alienate, assign, commute or otherwise encumber his benefit for any purpose
whatsoever, and any attempt to do so shall be disregarded completely as null and void. The provisions of this Plan shall be binding on the Executive and on each person who claims a benefit under him and on the Company. 

  

	Section 4.6	Self-Interest: The Executive shall not have any right to vote or decide upon any matter related directly or indirectly to him or any right to claim any benefit under this
Plan. 

  

	Section 4.7	Claims Procedures: The claims procedures shall be the same as under the Retirement Plan. 

  

 12 

	Section 4.8	Construction: This Plan shall be construed in accordance with the laws of the State of Georgia. The headings and subheadings in this Plan have been inserted for convenience
of reference only and are to be ignored in construction of the provisions of this Plan. In the construction of this Plan, the masculine shall include the feminine and the singular the plural wherever appropriate. 

  

 13 

 IN WITNESS WHEREOF, the Company has caused its duly authorized
officers to execute and seal this Plan as of this 29th day of December, 2006. 
  

			
	PLAN SPONSOR:
	
	CARAUSTAR INDUSTRIES, INC.
		
	 By:
	 	 /s/ Barry A. Smedstad

	 Title:
	 	Vice President, Human Resource
		 	

  

			
	(CORPORATE SEAL)
		
	 Attest:
	 	 /s/ Marinan R. Mays

	 Title:
	 	Corporate Director Benefits

  

 14 

 APPENDIX A 
 (The following provisions are applicable only to Thomas V. Brown and will supersede any respective provisions in the main document unless otherwise specified in this Appendix A. Any other provisions in the main document that have not been
superseded by this Appendix A Shall also apply to Mr. Brown.) 
  

	Section 2.4	Calculation Date: June 1, 2005. 

  

	Section 2.22	Retirement Date: July 1, 2005. 

  

	Section 2.23	Retirement Plan: The Caraustar Industries, Inc. Retirement Plan for Employees of Caraustar Industries, Inc. or the Smurfit Stone Pension Plan as amended from time to time.

  

	Section 2.24	Service: A period of employment beginning on December 7, 1962 and ending on the Employee’s Severance from Service. 

  

	Section 2.24.1	Social Security Benefit: The annual old-age or disability insurance benefit of an Employee under Title II of the Social Security Act as in effect on the date he retires or
otherwise terminates employment to which the Employee is or, upon proper application, would be entitled at his Normal Retirement Age, disregarding the effect on actual entitlement of any earnings of the Employee (generally known as the
“retirement test”). The Social Security Benefit shall be computed on the assumption that the Employee will receive no income after termination of employment, or Normal Retirement Age, if earlier, which would be treated as wages for
purposes of the Social Security Act. 

  

	Section 3.1	Accrued Benefit: The Accrued Benefit is an annual amount of $309,338.16, expressed as a single life annuity, calculated as of the Executive’s Calculation Date, equal to
the product of (A) times (B) minus (C) below, but not less than the Accrued Benefit determined under Section 3.1 of the main document. 

  

	 	(A)	is 1.5% of Average Annual Compensation offset by 1.5% of the Social Security Benefit, and 

  

	 	(B)	is years of Service (including a fraction for completed months) as of the Calculation Date, and 

  

	 	(C)	is the Accrued Benefit under all Retirement Plans as of the Calculation Date and the accrued benefit under any Company paid deferred Compensation arrangements as of the Calculation
Date. 

  

	Section 3.3	Benefit Payments: 

  

	 	(a)	 If a Payment Event occurs with respect to an Executive while an Executive is employed with the Company, and if such Executive’s benefits hereunder are vested,
then the Executive will receive his benefits 

  

 15 

	 	 
under a Fifty Percent (50%) Joint and Survivor Annuity, paid in monthly payments, with the initial annual amount being 90% of the Executive’s
Accrued Benefit, and with a 10-year guaranteed period (meaning that if the Executive dies less than 10 years after the commencement of the annuity payments, the Executive’s spouse or alternate Beneficiary will nevertheless receive the initial
annual amount of the annuity [ninety percent (90%) of the Accrued Benefit]). 

  

	 	(b)	Notwithstanding the above provisions of this Section 3.4, if the Executive is a Specified Employee at the time of the Payment Event, commencement of his Retirement Payments
shall be delayed until January 1, 2006. 

  

	 	(c)	On or after January 1, 2006, subject to the provisions of Section 3.2, the Executive shall receive an initial payment of $162,402.52, which amount includes the aggregate
of the prior six months of deferred payments since Mr. Brown’s June 1, 2005 retirement, including interest thereon at the interest rate most recently used to discount plan liabilities for FAS 87 purposes, and his regularly scheduled
monthly payment of $23,200.36. 

  

 16Series D Convertible Preferred Stock Purchase Agreement

 EXHIBIT 10.11 
 SERIES D CONVERTIBLE PREFERRED STOCK 
 PURCHASE AGREEMENT 
 THIS SERIES D CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (this
“Agreement”) is made and entered into effective as of January 24, 2007, by and among ODYSSEY MARINE EXPLORATION, INC., a Nevada corporation (the “Company”), and the investor(s) listed on
Schedule A attached hereto, each of which is herein individually referred to as an “Investor” and all of which are herein collectively referred to as the “Investors.” 
 Background Information: 
 The Company
proposes to authorize, issue, and sell to the Investors, and the Investors propose to purchase and accept from the Company, shares of the Company’s Series D Convertible Preferred Stock, par value $0.0001 per share (the
“Series D Shares”), with the terms and conditions as set forth in the Certificate of Designation and the Certificate of Amendment to Certificate of Designation in the forms attached hereto as Exhibit A (together, the
“Amended Certificate of Designation”). More specifically, the Company proposes to authorize, issue, and sell to the Investors (a) an aggregate of 2,200,000 Series D Shares and (b) warrants in substantially the form
attached hereto as Exhibit B-1 (the “Series D-1 Warrants”) to purchase up to an aggregate of 440,000 additional Series D Shares with an exercise price of $4.00 per share. In addition, the Company proposes to
authorize and issue to certain of the Investors warrants in substantially the form attached hereto as Exhibit B-2 (the “Series D-2 Warrants” and, together with the Series D-1 Warrants, the “Series D
Warrants”) to purchase up to an aggregate of 2,200,000 additional Series D Shares with an exercise price of $3.50 per share. Series D-2 Warrants to purchase Series D Shares shall be issued to each of the Investors that holds
a Warrant to Purchase Common Stock of the Company (the “Common Stock Warrants”) issued to such Investor in March 2005, against surrender for cancellation by such Investor of all of the Common Stock Warrants held by such Investor.
The purpose of this Agreement is to set forth the terms and conditions upon which (i) the Company will issue and sell the Series D Shares and the Series D-1 Warrants to the Investors and the Investors will purchase the Series D
Shares and accept the Series D-1 Warrants from the Company and (ii) certain Investors will exchange their Common Stock Warrants for Series D-2 Warrants, as well as certain other related matters. 
 NOW, THEREFORE, in consideration of the foregoing recitals and the terms, conditions, and provisions hereof, the parties hereto, intending to be
legally bound hereby, agree as follows: 
 Article 1 
 Purchase and Sale of Securities 
 Section 1.1 Sale and Issuance of Series D Shares and
Series D-1 Warrants and exchange of Series D-2 Warrants. 
 (a) The Company has adopted and filed, or shall adopt and file with the
Secretary of State of Nevada on or before the Closing (as defined below), the Amended Certificate of Designation. 
 (b) On or prior to the
Closing (as defined below), the Company shall have authorized (i) the sale and issuance to the Investors of the Series D Shares, (ii) the issuance to the Investors of the Series D Warrants, (iii) the issuance of any
Series D Shares to be issuable upon exercise of the Series D Warrants, and (iv) the issuance of the shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), to be issuable upon
conversion of the Series D Shares, including upon conversion of any Series D 

  

 1 

 
Shares that may be purchased upon exercise of the Series D Warrants (the “Conversion Shares”). The Series D Shares shall have the
rights, preferences, privileges and restrictions set forth in the Amended Certificate of Designation. 
 (c) Subject to the terms and
conditions of this Agreement, (i) each Investor agrees to purchase at the Closing, and the Company agrees to sell and issue to each Investor at the Closing, that number of Series D Shares and a Series D-1 Warrant to purchase that
number of Series D Shares set forth opposite such Investor’s name on Schedule A hereto for $3.00 per Series D Share (the “Series D Purchase Price”), and (ii) each of the Investors that holds Common
Stock Warrants agrees to surrender for cancellation at the Closing all of the Common Stock Warrants held by such Investor, and in exchange therefor the Company agrees to issue to such Investor a Series D-2 Warrant to purchase the same number of
Series D Shares as the number of shares of Common Stock for which the Common Stock Warrants surrendered for cancellation were exercisable. For the avoidance of doubt, Schedule A hereto also sets forth the number of shares of Common Stock
purchasable under the Common Stock Warrants to be surrendered by each Investor. 
 Section 1.2 Closing. The consummation of
purchase and sale of the Series D Shares and the issuance of the Series D Warrants (the “Closing”) shall take place at the offices of the Company, located at 5215 West Laurel Street, Tampa, Florida, on January 24,
2007, or at such other time and place as the Company and the Investors acquiring in the aggregate a majority of the Series D Shares sold pursuant to this Agreement agree upon orally or in writing (as applicable, the “Closing
Date”). At the Closing, or as soon as practicable thereafter, the Company shall deliver to each Investor a certificate representing the Series D Shares, the Series D-1 Warrant, and the Series D-2 Warrant that such Investor is
purchasing or acquiring against payment of the purchase price therefore by check, wire transfer, or any combination thereof. Payment by official bank check may be delivered to Odyssey Marine Exploration, Inc. 5215 West Laurel Street, Tampa, Florida
33607, or payment may be made by wire transfer of immediately available funds to: 
 The Bank of Tampa 
 4355 Henderson Boulevard 
 Tampa, Florida 33629 
 ABA# 063108680 
 For the account of Odyssey Marine Exploration, Inc. 
 Account Number: 31413706 
 Article 2 
 Representations and Warranties 
 of the Company 
 The Company hereby represents and warrants to the Investors as follows: 

Section 2.1 Organization. The Company is duly organized, validly existing, and in good standing under the laws of the State of Nevada. The
Company and each of its Subsidiaries (as defined in Rule 405 under the Securities Act of 1933, as amended (the “Securities Act”)) has full power and authority to own, operate and occupy its properties and to conduct its
business as presently conducted and as described in the documents filed by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including, without limitation, the Company’s Annual Report on
Form 10-K for the fiscal year ended December 31, 2005, the Company’s Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, June 30, and September 30, 2006, the Company’s Proxy Statement on
Schedule 14A for the Annual Meeting of Shareholders held May 5, 2006, and the Company’s Current Reports on Form 8-K, if any, since January 1, 2006 (collectively, the “Exchange Act Documents”), and is registered or

  

 2 

 
qualified to do business and in good standing in each jurisdiction in which the nature of the business conducted by it or the location of the properties
owned or leased by it requires such qualification and where the failure to be so qualified would have a material adverse effect upon the condition (financial or otherwise), earnings, business or business prospects, properties or operations of the
Company and its Subsidiaries, considered as one enterprise (a “Material Adverse Effect”), and no proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing, or seeking to revoke, limit or curtail, such
power and authority or qualification. 
 Section 2.2 Due Authorization and Valid Issuance. The Company has all requisite
corporate power and authority to execute, deliver and perform its obligations under this Agreement and the Series D Warrants (the “Transaction Documents”), and the Transaction Documents have been duly authorized and validly executed
and delivered by the Company and constitutes a legal, valid and binding agreement of the Company, enforceable against the Company in accordance with its terms, except as rights to indemnity and contribution may be limited by state or federal
securities laws or the public policy underlying such laws, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ and contracting parties’ rights
generally, and except as enforceability may be subject to general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law). The Series D Shares and the Series D Warrants have been duly
authorized and, upon issuance in accordance with the terms of this Agreement, shall be validly issued and free from all taxes, liens and charges with respect to the issue thereof, and the Series D Shares shall be fully paid and nonassessable.
As of the Closing Date, the Company shall have duly authorized and reserved for issuance a number of shares of Common Stock which equals the number of Conversion Shares. Upon conversion in accordance with the Amended Certificate of Designation, the
Conversion Shares will be validly issued, fully paid and nonassessable and free from all taxes, liens and charges with respect to the issue thereof, with the holders being entitled to all rights accorded to a holder of Common Stock. 
 Section 2.3 Non-Contravention. The execution and delivery of this Agreement, the issuance and sale of the Series D Shares and the Series
D Warrants under this Agreement, the fulfillment of the terms of this Agreement and the consummation of the transactions contemplated hereby will not (a) conflict with or constitute a violation of, or default (with the passage of time or
otherwise) under, (i) any material bond, debenture, note or other evidence of indebtedness, lease, contract, indenture, mortgage, deed of trust, loan agreement, joint venture or other agreement or instrument to which the Company or any
Subsidiary is a party or by which it or any of its Subsidiaries or their respective properties are bound, (ii) the articles of incorporation, bylaws or other organizational documents of the Company or any Subsidiary, or (iii) any law,
administrative regulation, ordinance or order of any court or governmental agency, arbitration panel or authority applicable to the Company or any Subsidiary or their respective properties, except in the case of clauses (i) and (iii) for
any such conflicts, violations or defaults which are not reasonably likely to have a Material Adverse Effect, or (b) result in the creation or imposition of any lien, encumbrance, claim, security interest or restriction whatsoever upon any of
the material properties or assets of the Company or any Subsidiary or an acceleration of indebtedness pursuant to any obligation, agreement or condition contained in any material bond, debenture, note or any other evidence of indebtedness or any
material indenture, mortgage, deed of trust or any other agreement or instrument to which the Company or any Subsidiary is a party or by which any of them is bound or to which any of the material property or assets of the Company or any Subsidiary
is subject. No consent, approval, authorization or other order of, or registration, qualification or filing with, any regulatory body, administrative agency, or other governmental body in the United States or any other person is required for the
execution and delivery of this Agreement, the valid issuance and sale of the Series D Shares to be sold pursuant to this Agreement, and the valid issuance of the Series D Warrants to be issued pursuant to this Agreement, other than such as
have been made or obtained, and except for any post-closing securities filings or notifications required to be made under federal or state securities laws or under the rules of American Stock Exchange. 
  

 3 

 Section 2.4 Capitalization. As of the date of this Agreement, the authorized capital stock of
the Company consists of (a) 100,000,000 shares of Common Stock, of which as of the date of this Agreement, 46,785,254 shares are issued and outstanding, 4,033,345 shares are reserved for issuance pursuant to the Company’s employee
incentive plan or plans, and 5,870,000 shares are reserved for issuance pursuant to securities (other than the Series D Shares and the Series D Warrants to be issued and sold pursuant to this Agreement) exercisable or exchangeable for, or
convertible into, shares of Common Stock, and (b) 9,300,000 shares of preferred stock, of which 2,500,000 shares have been designated as Series D Shares, all of which Series D Shares are issued and outstanding as of the date of this
Agreement (without giving effect to the issuance and sale of the Series D Shares pursuant to this Agreement). All of such outstanding shares have been, or upon issuance will be, validly issued and are fully paid and nonassessable. Except as
disclosed in the Exchange Act Documents: (a) no shares of the Company’s capital stock are subject to preemptive rights or any other similar rights or any liens or encumbrances suffered or permitted by the Company; (b) there are no
outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable for, any shares of capital stock of the Company or
any of its Subsidiaries, or contracts, commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become bound to issue additional shares of capital stock of the Company or any of its Subsidiaries or
options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable for, any shares of capital stock of the Company or any of its
Subsidiaries; (c) there are no outstanding debt securities, notes, credit agreements, credit facilities or other agreements, documents or instruments evidencing indebtedness of the Company or any of its Subsidiaries or by which the Company or
any of its Subsidiaries is or may become bound; (d) there are no agreements or arrangements under which the Company or any of its Subsidiaries is obligated to register the sale of any of their securities under the Securities Act except pursuant
to this Agreement and as disclosed on Exhibit C attached hereto; (e) there are no outstanding securities or instruments of the Company or any of its Subsidiaries which contain any redemption or similar provisions, and there are no
contracts, commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become bound to redeem a security of the Company or any of its Subsidiaries; (f) there are no securities or instruments containing
anti-dilution or similar provisions that will be triggered by the issuance of the Series D Shares, the Series D Warrants or the Conversion Shares; (g) the Company does not have any stock appreciation rights or “phantom stock”
plans or agreements or any similar plan or agreement; and (h) the Company and its Subsidiaries have no liabilities or obligations required to be disclosed in the Exchange Act Documents but not so disclosed in the Exchange Act Documents, other
than those incurred in the ordinary course of the Company’s or any Subsidiary’s respective businesses and which, individually or in the aggregate, do not or would not have a Material Adverse Effect. 
 Section 2.5 Legal Proceedings. There is no material legal or governmental proceeding pending or, to the knowledge of the Company, threatened
to which the Company or any Subsidiary is or may be a party or of which the business or property of the Company or any Subsidiary is subject that is not disclosed in the Exchange Act Documents. 
 Section 2.6 No Violations. Neither the Company nor any Subsidiary is in violation of its articles of incorporation, bylaws, or other
organizational document, or in violation of any law, administrative regulation, ordinance or order of any court or governmental agency, arbitration panel or authority applicable to the Company or any Subsidiary, which violation, individually or in
the aggregate, would be reasonably likely to have a Material Adverse Effect, or is in default (and there exists no condition which, with the passage of time or otherwise, would constitute a default) in any material respect in the performance of any
bond, debenture, note or any other 

  

 4 

 
evidence of indebtedness in any indenture, mortgage, deed of trust or any other material agreement or instrument to which the Company or any Subsidiary is a
party or by which the Company or any Subsidiary is bound or by which the properties of the Company or any Subsidiary are bound, which would be reasonably likely to have a Material Adverse Effect. 
 Section 2.7 Governmental Permits, Etc. With the exception of the matters which are dealt with separately in Sections 2.1, 2.12, 2.13,
and 2.14, each of the Company and its Subsidiaries has all necessary franchises, licenses, certificates and other authorizations from any foreign, federal, state or local government or governmental agency, department, or body that are currently
necessary for the operation of the business of the Company and its Subsidiaries as currently conducted and as described in the Exchange Act Documents, except where the failure to currently possess such franchises, licenses, certificates or other
authorizations would not reasonably be expected to have a Material Adverse Effect. 
 Section 2.8 Intellectual Property. Except
as specifically disclosed in the Exchange Act Documents (a) each of the Company and its Subsidiaries owns or possesses sufficient rights to use all material patents, patent rights, trademarks, copyrights, licenses, inventions, trade secrets,
trade names and know-how (collectively, “Intellectual Property”) described or referred to in the Exchange Act Documents as owned or possessed by it or that are necessary for the conduct of its business as now conducted or as
proposed to be conducted as described in the Exchange Act Documents except where the failure to currently own or possess such rights would not have a Material Adverse Effect, (b) neither the Company nor any of its Subsidiaries is infringing, or
has received any notice of, or has any knowledge of, any asserted infringement by the Company or any of its Subsidiaries of, any rights of a third party with respect to any Intellectual Property that, individually or in the aggregate, would have a
Material Adverse Effect and (c) neither the Company nor any of its Subsidiaries has received any notice of, or has any knowledge of, infringement by a third party with respect to any Intellectual Property rights of the Company or of any
Subsidiary that, individually or in the aggregate, would have a Material Adverse Effect. 
 Section 2.9 Exchange Act Documents;
Financial Statements. As of their respective dates, the Exchange Act Documents complied in all material respects with the requirements of the Exchange Act and the rules and regulations of United States Securities and Exchange Commission (the
“SEC”) promulgated thereunder applicable to the Exchange Act Documents, and none of the Exchange Act Documents, at the time they were filed or are to be filed with the SEC, contained or will contain any untrue statement of a
material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The financial statements of the
Company and the related notes contained in the Exchange Act Documents present fairly in all material respects, in accordance with generally accepted accounting principles, the financial position of the Company and its Subsidiaries as of the dates
indicated, and the results of its operations and cash flows for the periods therein specified consistent with the books and records of the Company and its Subsidiaries. Such financial statements (including the related notes) have been prepared in
accordance with generally accepted accounting principles applied on a consistent basis throughout the periods therein specified, except as may be disclosed in the notes to such financial statements, and except as disclosed in the Exchange Act
Documents. The other financial information contained in the Exchange Act Documents has been prepared on a basis consistent with the financial statements of the Company. 
 Section 2.10 No Material Adverse Change. Except as disclosed in the Exchange Act Documents, since December 31, 2005, there has not been (a) any material adverse change in the financial condition
of the Company and its Subsidiaries considered as one enterprise, (b) any material adverse event affecting the Company or its Subsidiaries, (c) any obligation, direct or contingent, that is material to the Company and its Subsidiaries
considered as one enterprise, incurred by the Company, except obligations incurred in 

  

 5 

 
the ordinary course of business, (d) any dividend or distribution of any kind declared, paid or made on the capital stock of the Company or any of its
Subsidiaries, or (e) any loss or damage (whether or not insured) to the physical property of the Company or any of its Subsidiaries which has been sustained which has had a Material Adverse Effect. 
 Section 2.11 American Stock Exchange Compliance. The Common Stock is registered pursuant to Section 12(b) or Section 12(g) of the
Exchange Act and is listed on American Stock Exchange (the “Principal Market”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange
Act or de-listing the Common Stock from the Principal Market, nor, except as disclosed in the Exchange Act Documents, has the Company received any notification that the SEC or the Principal Market is contemplating terminating such registration or
listing. 
 Section 2.12 Reporting Status. The Company has filed in a timely manner all documents that the Company was required
to file under the Exchange Act during the 12 months preceding the date of this Agreement. 
 Section 2.13 Listing. The Company
shall comply with all requirements of the Principal Market with respect to the issuance of the Series D Shares, the Series D Warrants, and the Conversion Shares and the listing of the Conversion Shares on the Principal Market in accordance
with the terms of the Amended Certificate of Designation. 
 Section 2.14 No Manipulation of Stock. The Company has not taken and
will not, in violation of applicable law, take any action designed to or that would reasonably be expected to cause or result in stabilization or manipulation of the price of the Common Stock to facilitate the sale or resale of the Series D
Shares. 
 Section 2.15 Company not an “Investment Company.” The Company has been advised of the rules and requirements
under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The Company is not, and immediately after receipt of payment for the Series D Shares and the Series D-1 Warrants will not be, an
“investment company” or an entity “controlled” by an “investment company” within the meaning of the Investment Company Act and shall conduct its business in a manner so that it will not become subject to the Investment
Company Act. 
 Section 2.16 Foreign Corrupt Practices. Neither the Company nor, to the knowledge of the Company, any agent or
other person acting on behalf of the Company has (a) directly or indirectly, used any corrupt funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (b) made any
unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (c) failed to disclose fully any contribution made by the Company (or made by any
person acting on its behalf of which the Company is aware) which is in violation of law, or (d) violated in any material respect any provision of the Foreign Corrupt Practices Act of 1977, as amended. 
 Section 2.17 Contracts. The contracts described in the Exchange Act Documents that are material to the Company are in full force and effect
on the date of this Agreement, and neither the Company nor, to the Company’s knowledge, any other party to such contracts is in breach of or default under any of such contracts which would have a Material Adverse Effect. 
 Section 2.18 Taxes. The Company has filed all necessary federal, state and foreign income and franchise tax returns and has paid or accrued
all taxes shown as due thereon, and the Company has no knowledge of a tax deficiency which has been or might be asserted or threatened against it which would have a Material Adverse Effect. 
  

 6 

 Section 2.19 Transfer Taxes. On the Closing Date, all stock transfer or other taxes (other
than income taxes) which are required to be paid in connection with the sale and transfer of the Series D Shares to be sold to the Investors pursuant to this Agreement will be, or will have been, fully paid or provided for by the Company and
all laws imposing such taxes will be or will have been fully complied with. 
 Section 2.20 Private Offering. Assuming the
accuracy and correctness of the representations and warranties of the Investors set forth in Article 3 of this Agreement, the offer and sale of the Series D Shares and the issuance of the Series D Warrants pursuant to this Agreement
is exempt from registration under the Securities Act. The Company has not distributed and will not distribute prior to the Closing Date any offering material in connection with the offer and sale of the Series D Shares and the issuance of the
Series D Warrants other than the documents of which this Agreement is a part or the Exchange Act Documents. The Company has not in the past nor will it hereafter take any action to sell, offer for sale or solicit offers to buy any securities of
the Company which would bring the offer, issuance or sale of the Series D Shares and the issuance of the Series D Warrants, as contemplated by this Agreement, within the provisions of Section 5 of the Securities Act, unless such
offer, issuance or sale was or shall be within the exemptions of Section 4 of the Securities Act. 
 Section 2.21 Internal
Accounting and Disclosure Controls. The Company and each of its Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that (a) transactions are executed in accordance with
management’s general or specific authorizations, (b) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles and to maintain asset and liability
accountability, (c) access to assets or incurrence of liabilities is permitted only in accordance with management’s general or specific authorization and (d) the recorded accountability for assets and liabilities is compared with the
existing assets and liabilities at reasonable intervals and appropriate action is taken with respect to any difference. The Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-14 under the Exchange Act)
that are effective in ensuring that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and
forms of the SEC, including, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to
the Company’s management, including its principal executive officer or officers and its principal financial officer or officers, as appropriate, to allow timely decisions regarding required disclosure. 
 Section 2.22 Disclosure. The representations and warranties of the Company contained in this Article 2, as of the date of this Agreement
and as of the Closing Date, do not and will not intentionally contain any untrue statement of a material fact or intentionally omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the
circumstances under which they were made, not misleading. 
 Article 3 
 Representations and Warranties 
 of the Investors 
 Each Investor, severally and not jointly, hereby represents and warrants to the Company as follows: 
 Section 3.1 Authorization. Such Investor has full power and authority to enter into this Agreement, and this Agreement constitutes its valid
and legally binding obligation, enforceable in accordance with its terms, except as rights to indemnity and contribution may be limited by state or federal securities laws or the public policy underlying such laws, except as enforceability may be
limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ and contracting parties’ rights generally, and except as enforceability may be subject to general principles of equity
(regardless of whether such enforceability is considered in a proceeding in equity or at law). 
  

 7 

 Section 3.2 Purchase Entirely for Own Account. This Agreement is made with such Investor in
reliance upon such Investor’s representation to the Company, which by such Investor’s execution of this Agreement such Investor hereby confirms, that the Series D Shares and the Series D Warrants to be received by such Investor
and the Conversion Shares (collectively, the “Securities”) will be acquired for investment for such Investor’s own account, not as a nominee or agent, and not with a view to the distribution of any part thereof, and that such
Investor has no present intention of selling, granting any participation in, or otherwise distributing the same. By executing this Agreement, such Investor further represents that such Investor does not have any contract, undertaking, agreement or
arrangement with any person to sell, transfer or grant participations to such person or to any third person, with respect to any of the Securities. 
 Section 3.3 Disclosure of Information. Such Investor believes it has received all the information it considers necessary or appropriate for deciding whether to purchase the Series D Shares and the Series D Warrants.
Such Investor further represents that it has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the offering of the Series D Shares, the Series D Warrants, and the business,
properties, prospects and financial condition of the Company. The foregoing, however, does not limit or modify the representations and warranties of the Company in Article 2 of this Agreement or the right of such Investor to rely thereon.

 Section 3.4 Investment Experience. Such Investor is a sophisticated investor and acknowledges that it is able to fend for
itself, can bear the economic risk of its investment, and has such knowledge and experience in financial or business matters that it is capable of evaluating the merits and risks of the investment in the Securities. If other than an individual,
Investor also represents it has not been organized for the purpose of acquiring the Securities. 
 Section 3.5 Accredited
Investor. Such Investor is an “accredited investor” within the meaning of SEC Rule 501 of Regulation D, as presently in effect. 
 Section 3.6 Restricted Securities. Such Investor understands that the Securities will be characterized as “restricted securities” under the federal securities laws inasmuch as they are being acquired from the Company
in a transaction not involving a public offering and that under such laws and applicable regulations such securities may be resold without registration under the Securities Act, only in certain limited circumstances. In this connection, such
Investor represents that it is familiar with SEC Rule 144, as presently in effect, and understands the resale limitations imposed thereby and by the Securities Act. 
 Section 3.7 Further Limitations on Disposition. Without in any way limiting the representations set forth above, such Investor further agrees not to make any disposition of all or any portion of the
Securities unless and until: 
 (a) there is then in effect a Registration Statement under the Securities Act covering such proposed
disposition and such disposition is made in accordance with such Registration Statement; or 
  

 8 

 (b) such Investor shall have notified the Company of the proposed disposition and shall have furnished
the Company with a detailed statement of the circumstances surrounding the proposed disposition, and, if reasonably requested by the Company, such Investor shall have furnished the Company with an opinion of counsel, reasonably satisfactory to the
Company that such disposition will not require registration of such shares under the Securities Act. 
 Section 3.8 Certain
Transactions. Such Investor has not, during the 10 days prior to the date of this Agreement, directly or indirectly traded in the Common Stock or established any hedge or other position in the Common Stock that is outstanding on the Closing Date
and that is designed to or could reasonably be expected to lead to or result in a direct or indirect sale, offer to sell, solicitation of offers to buy, disposition of, loan, pledge or grant of any right with respect to the Common Stock by such
Investor or any other person or entity. Such prohibited hedging or other transactions would include, without limitation, effecting any short sale or having in effect any short position (whether or not such sale or position is against the box and
regardless of when such position was entered into) or any purchase, sale or grant of any right (including without limitation any put or call option) with respect to the Common Stock or with respect to any security (other than a broad-based market
basket or index) that includes, relates to or derives any significant part of its value from the Common Stock. 
 Section 3.9
Legend. Such Investor acknowledges and agrees that the certificates evidencing the Securities may bear the following legend: 
 These
securities have not been registered under the Securities Act of 1933, as amended. They may not be sold, offered for sale, pledged or hypothecated in the absence of a registration statement in effect with respect to the securities under such Act or
an opinion of counsel satisfactory to the Company that such registration is not required or unless sold pursuant to Rule 144 of such Act. 
 The
legend set forth above shall be removed and the Company shall issue a certificate or other instruments without such legend to the holder of the Securities upon which it is stamped, if, unless otherwise required by state securities laws or
regulations, (i) such Securities are registered for resale under the Securities Act, (ii) in connection with a sale, assignment or other transfer, such holder provides the Company with an opinion of counsel, in a form reasonably acceptable
to the Company, to the effect that such sale, assignment or transfer of the Securities may be made without registration under the applicable requirements of the Securities Act, or (iii) such holder provides the Company with an opinion of
counsel, in a form reasonably acceptable to the Company, to the effect that the Securities can be sold, assigned or transferred pursuant to Rule 144 or Rule 144A. 
 Section 3.10 Exculpation Among Investors. Such Investor acknowledges that it is not relying upon any person, firm or corporation, other than the Company and its officers and directors, in making its
investment or decision to invest in the Company. Such Investor agrees that no Investor nor the respective controlling persons, officers, directors, partners, agents, or employees of any Investor shall be liable to any other Investor for any action
heretofore or hereafter taken or omitted to be taken by any of them in connection with the issuance and purchase of the Series D Shares and the Series D Warrants. 
 Section 3.11 Further Representations by Foreign Investors. If an Investor is not a United States person, such Investor hereby represents that
he or she has satisfied himself or herself as to the full observance of the laws of his or her jurisdiction in connection with any invitation to subscribe for the Securities or any use of this Agreement, including (a) the legal requirements
within his jurisdiction for the purchase of the Securities, (b) any foreign exchange restrictions applicable to such purchase, (c) any governmental or other consents that may need to be obtained, and (d) the income tax and other tax
consequences, if any, that may be relevant to the 

  

 9 

 
purchase, holding, redemption, sale, or transfer of the Securities. Such Investor’s subscription and payment for, and his or her continued beneficial
ownership of the Securities, will not violate any applicable securities or other laws of his or her jurisdiction. 
 Article 4

 Conditions to the Investors’ 
 Obligations at Closing 
 The obligations of each Investor under subsection 1.1(c) of this Agreement
are subject to the fulfillment on or before the Closing of each of the following conditions, the waiver of which shall not be effective against any Investor who does not consent thereto: 
 Section 4.1 Representations and Warranties. The representations and warranties of the Company contained in Article 2 shall be true on
and as of the Closing with the same effect as though such representations and warranties had been made on and as of the date of such Closing. 
 Section 4.2 Performance. The Company shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by it on or before the
Closing. 
 Section 4.3 Compliance Certificate. The President or other appropriate officer of the Company shall deliver to the
Investors at the Closing a certificate stating that the conditions specified in Sections 4.1 and 4.2 have been fulfilled. 
 Section 4.4 Qualifications. All authorizations, approvals, or permits, if any, of any governmental authority or regulatory body of the United States or of any state that are required in connection with the lawful issuance, sale
and purchase of the Series D Shares and the Series D Warrants pursuant to this Agreement shall be duly obtained and effective as of the Closing. 
 Section 4.5 Proceedings and Documents. All corporate and other proceedings in connection with the transactions contemplated at the Closing and all documents incident thereto shall be reasonably
satisfactory in form and substance to the Investors, and they shall have received all such counterpart original and certified or other copies of such documents as they may reasonably request. 
 Article 5 
 Conditions to the Company’s 
 Obligations at Closing 
 The
obligations of the Company to each Investor under this Agreement are subject to the fulfillment on or before the Closing of each of the following conditions by that Investor: 
 Section 5.1 Representations and Warranties. The representations and warranties of the Investors contained in Article 3 shall be true on
and as of the Closing with the same effect as though such representations and warranties had been made on and as of the date of such Closing. 
 Section 5.2 Payment of Purchase Price. The Investors shall have delivered the Series D Purchase Price specified in Section 1.1(c). 
  

 10 

 Section 5.3 Qualifications. All authorizations, approvals, or permits, if any, of any
governmental authority or regulatory body of the United States or of any state that are required in connection with the lawful issuance, sale and purchase of the Series D Shares and the Series D Warrants pursuant to this Agreement shall be
duly obtained and effective as of the Closing. 
 Article 6 
 Registration Rights 
 Section 6.1 Certain Definitions. For purposes
of this Article 6: 
 (a) The term “Effectiveness Deadline” means the date which is (i) in the event that the
Registration Statement is not subject to a full review by the SEC, ninety (90) calendar days after the earlier of the Filing Date and the Filing Deadline (each as defined below) or (ii) in the event that the Registration Statement is
subject to a full review by the SEC, one hundred and twenty (120) calendar days after the Filing Date. 
 (b) The term “Filing
Date” means the date the Registration Statement is filed with the SEC. 
 (c) The term “Filing Deadline” means the
date which is the earlier of (i) twenty (20) calendar days after the Company files its Annual Report on Form 10-K for the year ended December 31, 2006 and (ii) ninety (90) calendar days after the Closing Date. 
 (d) The term “Form S-3” means such form under the Securities Act as in effect on the date of this Agreement or any registration form
under the Securities Act subsequently adopted by the SEC that permits inclusion or incorporation of substantial information by reference to other documents filed by the Company with the SEC. 
 (e) The term “Holder” means any person owning or having the right to acquire Registrable Securities or any assignee thereof in accordance
with Section 6.9 of this Agreement. 
 (f) The terms “register,” “registered,” and
“registration” refer to a registration effected by preparing and filing a Registration Statement or similar document in compliance with the Securities Act, and the declaration or ordering of effectiveness of such Registration
Statement or document. 
 (g) The term “Registrable Securities” means (i) the Conversion Shares, but only to the extent
that such Conversion Shares are issuable upon the conversion of Series D Shares that are issued and outstanding at the applicable time, and (ii) any Common Stock of the Company issued as (or issuable upon the conversion or exercise of any
warrant, right or other security that is issued as) a dividend or other distribution with respect to, or in exchange for, or in replacement of, the Conversion Shares. 
 (h) The number of shares of “Registrable Securities” outstanding shall be determined by the number of shares of Common Stock outstanding that are, and the number of shares of Common Stock issuable
pursuant to then exercisable or convertible securities that are, Registrable Securities. 
 (i) The term “Registration
Statement” means the registration statement that is filed with the SEC pursuant to the provisions of this Article 6. 
 (j) The term
“Rule 144” shall mean Rule 144 under the Securities Act. 
 (k) The term “Rule 144(k)” shall
mean subsection (k) of Rule 144 under the Securities Act. 
  

 11 

 Section 6.2 Registration. 
 (a) The Company shall prepare, and, as soon as practicable but in no event later than the Filing Deadline, file with the SEC the Registration Statement on
Form S-3 covering the resale of all of the Registrable Securities. In the event that Form S-3 is unavailable for such a registration, the Company shall use such other form as is available for such a registration on another appropriate form
reasonably acceptable to the Required Holders, subject to the provisions of Section 6.2(c). 
 (b) Allocation of Registrable
Securities. The initial number of Registrable Securities included in any Registration Statement and any increase in the number of Registrable Securities included therein shall be allocated pro rata among the Investors based on the number of
Registrable Securities held by each Investor at the time the Registration Statement covering such initial number of Registrable Securities or increase thereof is declared effective by the SEC. In the event that an Investor sells or otherwise
transfers any of such Investor’s Registrable Securities, each transferee shall be allocated a pro rata portion of the then remaining number of Registrable Securities included in such Registration Statement for such transferor. Any shares of
Common Stock included in a Registration Statement and which remain allocated to any Person which ceases to hold any Registrable Securities covered by such Registration Statement shall be allocated to the remaining Investors, pro rata based on the
number of Registrable Securities then held by such Investors which are covered by such Registration Statement. In no event shall the Company include any securities other than Registrable Securities on any Registration Statement without the prior
written consent of the Required Holders. 
 (c) Ineligibility for Form S-3. In the event that Form S-3 is not available for the
registration of the resale of Registrable Securities hereunder, the Company shall (i) register the resale of the Registrable Securities on another appropriate form reasonably acceptable to the Required Holders and (ii) undertake to
register the Registrable Securities on Form S-3 as soon as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in effect until such time as a Registration Statement on Form S-3
covering the Registrable Securities has been declared effective by the SEC. 
 Section 6.3 Obligations of the Company. Whenever
required under this Article 6 to effect the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible: 
 (a) keep each Registration Statement effective pursuant to Rule 415 at all times until the earlier of (i) the date as of which the Investors may sell all of the Registrable Securities covered by such Registration
Statement without restriction pursuant to Rule 144(k) (or any successor thereto) promulgated under the Securities Act or (ii) the date on which the Investors shall have sold all of the Registrable Securities covered by such Registration
Statement (the “Registration Period”); 
 (b) ensure that each Registration Statement (including any amendments or
supplements thereto and prospectuses contained therein) shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein (in the case of
prospectuses, in the light of the circumstances in which they were made) not misleading; 
 (c) permit the Investors to review and comment
upon (i) a Registration Statement at least five (5) Business Days prior to its filing with the SEC and (ii) all amendments and supplements to all Registration Statements (except for Annual Reports on Form 10-K, and Reports on Form
10-Q and any similar or successor reports) within a reasonable number of days prior to their filing with the SEC, and (B) not file any Registration Statement or amendment or supplement thereto in a form to which an Investor reasonably objects;

  

 12 

 (d) prepare and file with the SEC such amendments and supplements to such Registration Statement and the
prospectus used in connection with such Registration Statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such Registration Statement; 
 (e) furnish to the Holders such number of copies of a prospectus, including a preliminary prospectus, in conformity with the requirements of the
Securities Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them; 
 (f) use all commercially reasonable efforts to register and qualify the securities covered by such Registration Statement under such other securities or Blue Sky laws of such jurisdictions as shall be reasonably
requested by the Holders, provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service of process in any such states or jurisdictions; 

(g) in the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and customary
form, with the managing underwriter of such offering; 
 (h) notify each Holder of Registrable Securities covered by such Registration
Statement at any time when a prospectus relating thereto is required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in such Registration Statement, as then in effect, includes an
untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing; and 
 (i) cause all such Registrable Securities registered pursuant to this Article 6 to be listed on a national exchange or trading system and on each
securities exchange and trading system on which similar securities issued by the Company are then listed. 
 Notwithstanding the provisions
of this Article 6, the Company shall be entitled to postpone or suspend, for a period of time (each such period, a “Grace Period”), the filing, effectiveness or use of, or trading under, any Registration Statement if the
Company shall determine that any such filing or the sale of any securities pursuant to such Registration Statement would in the good faith judgment of the Board of Directors of the Company: 
 (i) materially impede, delay or interfere with any material pending or proposed financing, acquisition, corporate reorganization, or other
similar transaction involving the Company for which the Board of Directors of the Company has authorized negotiations; 
 (ii)
materially and adversely impair the consummation of any pending or proposed material offering or sale of any class of securities by the Company; or 
 (iii) require disclosure of material nonpublic information that, if disclosed at such time, would be materially harmful to the interests of the Company and its shareholders; provided, however, that during any
such period all executive officers and directors of the Company are also prohibited from selling securities of the Company (or any security of any of the Company’s subsidiaries or affiliates). 
  

 13 

 No Grace Period shall exceed fifteen (15) consecutive days and during any three hundred sixty five
(365) day period such Grace Periods shall not exceed an aggregate of forty-five days and the first day of any Grace Period must be at least five (5) trading days after the last day of any prior Grace Period. 
 Section 6.4 Information from Holder. It shall be a condition precedent to the obligations of the Company to take any action pursuant to this
Article 6 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended method of disposition of such
securities as shall be reasonably required to effect the registration of such Holder’s Registrable Securities. 
 Section 6.5
Expenses of Registration. All expenses other than underwriting discounts and commissions incurred in connection with registrations, filings or qualifications pursuant to Section 6.2, including (without limitation) all registration, filing
and qualification fees, printers’ and accounting fees, and fees and disbursements of counsel for the Company shall be borne by the Company. 
 Section 6.6 [Intentionally Omitted] 
 Section 6.7 Indemnification. In the event any Registrable Securities
are included in a Registration Statement under this Article 6: 
 (a) To the extent permitted by law, the Company will indemnify and hold
harmless each Holder, the partners, officers, directors and shareholders of each Holder, legal counsel and accountants for each Holder, any underwriter (as defined in the Securities Act) for such Holder and each person, if any, who controls such
Holder or underwriter within the meaning of the Securities Act or the Exchange Act, against any losses, claims, damages or liabilities (joint or several) to which they may become subject under the Securities Act, the Exchange Act, any state
securities laws or any rule or regulation promulgated under the Securities Act, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or
violations (collectively a “Violation”): (i) any untrue statement or alleged untrue statement of a material fact contained in such Registration Statement, including any preliminary prospectus or final prospectus contained
therein or any amendments or supplements thereto, (ii) any breach of any covenant, agreement or obligation of the Company contained in herein or any other certificate, instrument or document contemplated hereby or thereby (iii) the
omission or alleged omission to state in such Registration Statement a material fact required to be stated therein, or necessary to make the statements therein not misleading or (iv) any violation or alleged violation by the Company of the
Securities Act, the Exchange Act, any state securities laws or any rule or regulation promulgated under the Securities Act, the Exchange Act or any state securities laws, and the Company will reimburse each such Holder, underwriter, controlling
person or other aforementioned person for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action as such expenses are incurred; provided,
however, that the indemnity agreement contained in this Section 6.7(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Company
(which consent shall not be unreasonably withheld), nor shall the Company be liable in any such case for any such loss, claim, damage, liability or action to the extent that it arises out of or is based upon a Violation that occurs in reliance upon
and in conformity with written information furnished expressly for use in connection with such registration by any such Holder, underwriter, controlling person or other aforementioned person. 
 (b) To the extent permitted by law, each selling Holder will indemnify and hold harmless the Company, each of its directors, each of its officers who has
signed the Registration Statement, each person, if any, who controls the Company within the meaning of the Securities Act, legal counsel and accountants for the Company, any underwriter, any other Holder selling securities in such Registration
Statement and any controlling person of any such underwriter or other Holder, against any losses, claims, damages or 

  

 14 

 
liabilities (joint or several) to which any of the foregoing persons may become subject, under the Securities Act, the Exchange Act, any state securities
laws or any rule or regulation promulgated under the Securities Act, the Exchange Act or any state securities laws, insofar as such losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based upon any Violation,
in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written information furnished by such Holder expressly for use in connection with such registration; and each such Holder will
reimburse any person intended to be indemnified pursuant to this Section 6.7(b) for any legal or other expenses reasonably incurred by such person in connection with investigating or defending any such loss, claim, damage, liability or action
as such expenses are incurred; provided, however, that the indemnity agreement contained in this Section 6.7(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is
effected without the consent of the Holder (which consent shall not be unreasonably withheld), and provided that in no event shall any indemnity under this Section 6.7(b) exceed the net proceeds from the offering received by such Holder.

 (c) Promptly after receipt by an indemnified party under this Section 6.7 of notice of the commencement of any action (including any
governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 6.7, deliver to the indemnifying party a written notice of the commencement thereof and the
indemnifying party shall have the right to participate in and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the
parties; provided, however, that an indemnified party (together with all other indemnified parties that may be represented without conflict by one counsel) shall have the right to retain one separate counsel, with the fees and expenses to be
paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such indemnified party and any other party
represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action, if prejudicial to its ability to defend such action, shall relieve such
indemnifying party of any liability to the indemnified party under this Section 6.7, but the omission to so deliver written notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party
otherwise than under this Section 6.7. 
 (d) If the indemnification provided for in this Section 6.7 is held by a court of
competent jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim, damage or expense referred to herein, then the indemnifying party, in lieu of indemnifying such indemnified party hereunder, shall
contribute to the amount paid or payable by such indemnified party as a result of such loss, liability, claim, damage or expense in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and the
indemnified party on the other hand in connection with the statements or omissions that resulted in such loss, liability, claim, damage or expense, as well as any other relevant equitable considerations; provided, however, that no
contribution by any Holder, when combined with any amounts paid by such Holder pursuant to Section 6.7(b), shall exceed the net proceeds from the offering received by such Holder. The relative fault of the indemnifying party and the indemnified
party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the indemnifying party
or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. 
  

 15 

 (e) The obligations of the Company and Holders under this Section 6.7 shall survive the completion
of any offering of Registrable Securities in a Registration Statement under this Article 6 and otherwise. 
 Section 6.8 Reports
Under the Exchange Act. With a view to making available to the Holders the benefits of Rule 144 and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without
registration or pursuant to a registration on Form S-3, the Company agrees to: 
 (a) make and keep public information available, as those
terms are understood and defined in SEC Rule 144; 
 (b) file with the SEC in a timely manner all reports and other documents required of
the Company under the Securities Act and the Exchange Act; and 
 (c) furnish to any Holder, so long as the Holder owns any Registrable
Securities, forthwith upon request (i) a written statement by the Company that it has complied with the reporting requirements of Rule 144, the Securities Act and the Exchange Act, or that it qualifies as a registrant whose securities may
be resold pursuant to Form S-3 (at any time after it so qualifies), (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company, and (iii) such other information as
may be reasonably requested to avail any Holder of any rule or regulation of the SEC that permits the selling of any such securities without registration or pursuant to such form. 
 Section 6.9 Assignment of Registration Rights. The rights under this Agreement shall be automatically assignable by the Investors to any
transferee of all or any portion of such Investor’s Registrable Securities if: (i) the Investor agrees in writing with the transferee or assignee to assign such rights and a copy of such agreement is furnished to the Company within a
reasonable time after such assignment; (ii) the Company is, within a reasonable time after such transfer or assignment, furnished with written notice of (a) the name and address of such transferee or assignee and (b) the securities
with respect to which such registration rights are being transferred or assigned; (iii) immediately following such transfer or assignment the further disposition of such securities by the transferee or assignee is restricted under the
Securities Act or applicable state securities laws; (iv) at or before the time the Company receives the written notice contemplated by clause (ii) of this sentence the transferee or assignee agrees in writing with the Company to be bound
by all of the provisions contained herein; and (v) such transfer shall have been made in accordance with the applicable requirements of this Agreement. 
 Section 6.10 Termination of Registration Rights. No Holder shall be entitled to exercise any right provided for in this Article 6 (a) after the Registration Period. 
 Article 7 
 Miscellaneous

 Section 7.1 Survival of Warranties. The warranties, representations and covenants of the Company and the Investors
contained in or made pursuant to this Agreement shall survive the execution and delivery of this Agreement and the Closing and shall in no way be affected by any investigation of the subject matter thereof made by or on behalf of the Investors or
the Company. 
 Section 7.2 Successors and Assigns. Except as otherwise provided herein, the terms and conditions of this
Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties (including transferees of any Securities). Nothing in this Agreement, express or implied, is intended to confer upon any party other
than the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 
  

 16 

 Section 7.3 Governing Law. This Agreement shall be governed by and construed under the laws
of the State of Florida without reference to principles of choice or conflict of law thereunder. 
 Section 7.4 Counterparts.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
 Section 7.5 Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered
in construing or interpreting this Agreement. 
 Section 7.6 Notices. All notices and other communications given or made pursuant
hereto shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed facsimile if sent during normal business hours of the recipient; if not, then on the next
business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight courier, specifying next
day delivery, with written verification of receipt. All communications shall be sent to the Company at 5215 West Laurel Street, Tampa, Florida 33607 (Facsimile 813-876-1777) and to the respective Investors at the addresses set forth
Schedule A attached hereto (or at such other addresses as shall be specified by notice given in accordance with this Section 7.6). 
 Section 7.7 Finder’s Fee. Each party represents that it neither is nor will be obligated for any finders’ fee or commission in connection with this transaction. Each Investor agrees to indemnify and to hold harmless
the Company, and the Company agrees to indemnify and hold harmless each Investor, from any liability for any commission or compensation in the nature of a finders’ fee (and the costs and expenses of defending against such liability or asserted
liability) for which such Investor or any of its officers, partners, employees, or representatives is responsible. 
 Section 7.8
Expenses. Except as contemplated by Section 6.5, each of the parties to this Agreement shall bear its own expenses in connection with this Agreement and the transactions contemplated by this Agreement. If any action at law or in equity is
necessary to enforce or interpret the terms of this Agreement or the Amended Certificate of Designation, the prevailing party shall be entitled to reasonable attorney’s fees, costs and necessary disbursements in addition to any other relief to
which such party may be entitled. 
 Section 7.9 Amendments and Waivers. Any term of this Agreement may be amended and the
observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and the holders of a majority of the Conversion Shares
issued or issuable upon conversion of the Series D Shares purchased hereunder. Any amendment or waiver effected in accordance with this section shall be binding upon each holder of any securities purchased under this Agreement at the time
outstanding (including securities into which such securities are convertible), each future holder of all such securities, and the Company. 
 Section 7.10 Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision shall be excluded from this Agreement and the balance of the Agreement shall be interpreted
as if such provision were so excluded and shall be enforceable in accordance with its terms. 
  

 17 

 Section 7.11 Aggregation of Stock. All shares of the Series D Preferred Stock held or
acquired by affiliated entities or persons shall be aggregated together for the purpose of determining the availability of any rights under this Agreement. For purposes of Article 6, all shares of Registrable Securities held or acquired by
affiliated entities (including affiliated venture capital funds) or persons shall be aggregated together for the purpose of determining the availability of any rights under this Agreement. 
 Section 7.12 Entire Agreement. This Agreement and the documents referred to herein constitute the entire agreement among the parties and no
party shall be liable or bound to any other party in any manner by any warranties, representations, or covenants except as specifically set forth herein or therein. 
 Section 7.13 Independent Nature of Buyers’ Obligations and Rights. The obligations of each Investor under any Transaction Document are several and not joint with the obligations of any other Investor,
and no Investor shall be responsible in any way for the performance of the obligations of any other Investor under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Investor pursuant
hereto or thereto, shall be deemed to constitute the Investor as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Investor are in any way acting in concert or as a group with respect to
such obligations or the transactions contemplated by the Transaction Documents. Each Investor confirms that it has independently participated in the negotiation of the transaction contemplated hereby with the advice of its own counsel and advisors.
Each Investor shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out of any other Transaction Documents, and it shall not be necessary for any other Investor
to be joined as an additional party in any proceeding for such purpose. 
 [Signatures on following page.] 
  

 18 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.

  

					
	ODYSSEY MARINE EXPLORATION, INC.
			
		 	By:	 	  

			
		 	Name:	 	  

			
		 	Title:	 	  

	
	GLG NORTH AMERICAN OPPORTUNITY FUND
		 	By: GLG Partners, LP, Investment Manager
			
		 	By:	 	  

			
		 	Print Name:	 	  

			
		 	Title:	 	  

	
	GLG INVESTMENTS PLC
		 	Sub-Fund: GLG Capital Appreciation Fund
		 	By: GLG Partners, LP, Investment Manager
			
		 	By:	 	  

			
		 	Print Name:	 	  

			
		 	Title:	 	  

	
	GLG INVESTMENTS IV PLC
		 	Sub-Fund: GLG Capital Appreciation (Distributing) Fund
		 	By: GLG Partners, LP, Investment Manager
			
		 	By:	 	  

			
		 	Print Name:	 	  

			
		 	Title:	 	  

	
	GLG INVESTMENTS PLC
		 	Sub-Fund: GLG Balanced Fund
		 	By: GLG Partners, LP, Investment Manager
			
		 	By:	 	  

			
		 	Print Name:	 	  

			
		 	Title:	 	  

  

 19 

					
	GLG INVESTMENTS PLC
	 	 	Sub-Fund: GLG North American Equity Fund
	 	 	By: GLG Partners, LP, Investment Manager
			
		 	By:	 	  

			
		 	Print Name:	 	  

			
		 	Title:	 	  

	
	PLÉIADE SICAV
		 	Sub-Fund: Pléiade Actions Amérique du Nord
		 	By: GLG Partners, LP, Investment Manager
			
		 	By:	 	  

			
		 	Print Name:	 	  

			
		 	Title:	 	  

	
	THE CENTURY FUND SICAV
		 	By: GLG Partners, LP, Investment Manager
			
		 	By:	 	  

			
		 	Print Name:	 	  

			
		 	Title:	 	  

	
	DRAWBRIDGE GLOBAL MACRO MASTER FUND LTD.
			
		 	By:	 	  

			
		 	Print Name:	 	  

			
		 	Title:	 	  

  

 20 

 SCHEDULE A 
 Schedule of Investors 
  

								
	 Name and Address
	  	 Number of
 Series D Shares Purchased
	  	 Total Purchase Price
	  	 Number of Series D Shares
 For Which
 Series D-1 Warrant Exercisable

	  	  	  
	  	  	  
	GLG NORTH AMERICAN OPPORTUNITY FUND	  	600,000	  	$	1,800,000.00	  	120,000
				
	 GLG INVESTMENTS PLC
 Sub-Fund: GLG Capital
Appreciation Fund
	  	141,000	  	$	423,000.00	  	28,200
				
	 GLG INVESTMENTS IV PLC
 Sub-Fund: GLG Capital
Appreciation (Distributing) Fund
	  	75,000	  	$	225,000.00	  	15,000
				
	 GLG INVESTMENTS PLC
 Sub-Fund: GLG Balanced
Fund
	  	10,000	  	$	30,000.00	  	2,000
				
	 GLG INVESTMENTS PLC
 Sub-Fund: GLG North
American Equity Fund
	  	135,000	  	$	405,000.00	  	27,000
				
	 PLÉIADE SICAV
 Sub-Fund: Pléiade
Actions Amérique du Nord
	  	12,000	  	$	36,000.00	  	2,400
				
	THE CENTURY FUND SICAV	  	27,000	  	$	81,000.00	  	5,400

  

			
	GLG NORTH AMERICAN OPPORTUNITY FUND	  	 
	Number of Shares of Common Stock Purchasable Under
Common Stock Warrants Surrendered:	  	1,000,000
	  

 Contact Information for All Entities: 
 c/o GLG Partners LP 
 Attention: Gitesh Parmar 
 One Curzon Street 
 London W1J 5HB 
 United Kingdom 
 Phone: +44 20 7016 7000 
 Fax: +44 20
7016 7200 
  

 21 

 SCHEDULE A 
 Schedule of Investors (Continued) 
  

								
	 Name and Address
	  	 Number of
 Series D Shares Purchased
	  	 Total Purchase Price
	  	 Number of Series D Shares
 For Which
 Series D-1 Warrant Exercisable

	  	  	  
	  	  	  
	DRAWBRIDGE GLOBAL MACRO MASTER FUND LTD.	  	1,200,000	  	$	3,600,000.00	  	240,000

  

			
	DRAWBRIDGE GLOBAL MACRO MASTER FUND LTD	 	
	Number of Shares of Common Stock
Purchasable Under Common Stock Warrants Surrendered:	 	1,200,000

 Contact Information for Drawbridge Global Macro Master Fund 
 Jaime Mendez 
 Goldman Sachs 
 Global Securities Services – Prime Brokerage 
 One New York Plaza, 44th Floor 
 New York, NY 10004 
 Tel: (212) 367-9328 
  

 22 

 EXHIBIT A 
 Amended Certificate of Designation 
 See attached Amended Certificate of Designation. 

 EXHIBIT B-1 
 Form of Series D-1 Warrant 
 See attached Form of Series D-1 Warrant. 

 EXHIBIT B-2 
 Form of Series D-2 Warrant 
 See attached Form of Series D-2 Warrant. 

 EXHIBIT C 
 Registration Rights 
  

	 	•	 	 In March 2006, the Company issued and sold an aggregate of 2,500,000 shares of its Series D Convertible Preferred Stock to five funds controlled by two
institutional investors. Pursuant to Article 6 of the Series D Convertible Preferred Stock Purchase Agreement dated as of March 13, 2006, among the Company and the holders of the Series D Convertible Preferred Stock, such holders
are entitled to request that the Company prepare and file a registration statement relating to the offer and sale of the Company’s common stock issuable upon exercise of the Series D Convertible Preferred Stock. As of the date of this
Agreement, such holders have not requested registration of such shares. 

  

	 	•	 	 In November 2006, the Company issued and sold an aggregate of 500,000 shares of common stock and warrants to purchase an aggregate of 100,000 shares of common stock
to three investors. Pursuant to Section 7 of the Terms and Conditions relating to the Securities Purchase Agreements dated November 22, 2006, between the Company and the investors, the Company agreed to prepare and file a registration
statement relating to the offer and sale of the shares of common stock sold to the investors and the shares of common stock issuable upon exercise of the warrants issued to the investors. The Company agreed to prepare and file such registration
statement within 60 days of the completion of the transaction, or January 22, 2007.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00119-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00119-of-00352.parquet"}]]